These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 25354787)

  • 1. A prodrug approach involving in situ depot formation to achieve localized and sustained action of diclofenac after joint injection.
    Thing M; Ågårdh L; Larsen S; Rasmussen R; Pallesen J; Mertz N; Kristensen J; Hansen M; Østergaard J; Larsen CS
    J Pharm Sci; 2014 Dec; 103(12):4021-4029. PubMed ID: 25354787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Acting Diclofenac Ester Prodrugs for Joint Injection: Kinetics, Mechanism of Degradation, and In Vitro Release From Prodrug Suspension.
    Mertz N; Larsen SW; Kristensen J; Østergaard J; Larsen C
    J Pharm Sci; 2016 Oct; 105(10):3079-3087. PubMed ID: 27475785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of concomitant drug release from oil vehicles using drug-prodrug combinations to achieve sustained balanced analgesia after joint installation.
    Thing M; Jensen SS; Larsen C; Østergaard J; Larsen SW
    Int J Pharm; 2012 Dec; 439(1-2):246-53. PubMed ID: 23010284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel diclofenac-hydrogel conjugate system for intraarticular sustained release: Development of 2-pyridylamino-substituted 1-phenylethanol (PAPE) and its derivatives as tunable traceless linkers.
    Kawanami T; LaBonte LR; Amin J; Thibodeaux SJ; Lee CC; Argintaru OA; Adams CM
    Int J Pharm; 2020 Jul; 585():119519. PubMed ID: 32535069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diclofenac Prodrugs for Intra-articular Depot Injectables: In Vitro Hydrolysis and Species Variation.
    Storgaard IH; Kristensen J; Larsen C; Mertz N; Østergaard J; Larsen SW
    J Pharm Sci; 2020 Apr; 109(4):1529-1536. PubMed ID: 31927039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged naproxen joint residence time after intra-articular injection of lipophilic solutions comprising a naproxen glycolamide ester prodrug in the rat.
    Thing M; Lu Y; Agårdh L; Larsen C; Ostergaard J; He W; Wu W; Larsen F; Larsen SW
    Int J Pharm; 2013 Jul; 451(1-2):34-40. PubMed ID: 23624087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipid-drug conjugates as a novel oral drug targeting approach for the treatment of inflammatory bowel disease.
    Dahan A; Markovic M; Epstein S; Cohen N; Zimmermann EM; Aponick A; Ben-Shabat S
    Eur J Pharm Sci; 2017 Oct; 108():78-85. PubMed ID: 28627471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrospun poly-l-lactide scaffold for the controlled and targeted delivery of a synthetically obtained Diclofenac prodrug to treat actinic keratosis.
    Piccirillo G; Bochicchio B; Pepe A; Schenke-Layland K; Hinderer S
    Acta Biomater; 2017 Apr; 52():187-196. PubMed ID: 27816622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of a nonsteroidal anti-inflammatory polymeric prodrug for sustained and site-specific delivery.
    Chandrasekar MJ; Ravichandran M; Nanjan MJ; Suresh B
    Drug Dev Ind Pharm; 2001 Oct; 27(9):959-64. PubMed ID: 11763474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morpholinoalkyl ester prodrugs of diclofenac: synthesis, in vitro and in vivo evaluation.
    Tammara VK; Narurkar MM; Crider AM; Khan MA
    J Pharm Sci; 1994 May; 83(5):644-8. PubMed ID: 8071813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disappearance kinetics of solutes from synovial fluid after intra-articular injection.
    Owen SG; Francis HW; Roberts MS
    Br J Clin Pharmacol; 1994 Oct; 38(4):349-55. PubMed ID: 7833225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone-specific delivery and sustained release of diclofenac, a non-steroidal anti-inflammatory drug, via bisphosphonic prodrug based on the Osteotropic Drug Delivery System (ODDS).
    Hirabayashi H; Takahashi T; Fujisaki J; Masunaga T; Sato S; Hiroi J; Tokunaga Y; Kimura S; Hata T
    J Control Release; 2001 Jan; 70(1-2):183-91. PubMed ID: 11166418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained Pulmonary Delivery of a Water-Soluble Antibiotic Without Encapsulating Carriers.
    Ong W; Nowak P; Cu Y; Schopf L; Bourassa J; Enlow E; Moskowitz SM; Chen H
    Pharm Res; 2016 Mar; 33(3):563-72. PubMed ID: 26508478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electroporation-enhanced transdermal diclofenac sodium delivery into the knee joint in a rat model of acute arthritis.
    Hartmann P; Butt E; Fehér Á; Szilágyi ÁL; Jász KD; Balázs B; Bakonyi M; Berkó S; Erős G; Boros M; Horváth G; Varga E; Csányi E
    Drug Des Devel Ther; 2018; 12():1917-1930. PubMed ID: 29983546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diclofenac-β-cyclodextrin for colonic drug targeting: In vivo performance in rats.
    Vieira AC; Serra AC; Veiga FJ; Gonsalves AM; Basit AW; Murdan S
    Int J Pharm; 2016 Mar; 500(1-2):366-70. PubMed ID: 26784980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological effects of N-[2-[[2-[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]ethyl]hyaluronamide (diclofenac Etalhyaluronate, SI-613), a novel sodium hyaluronate derivative chemically linked with diclofenac.
    Yoshioka K; Kisukeda T; Zuinen R; Yasuda Y; Miyamoto K
    BMC Musculoskelet Disord; 2018 May; 19(1):157. PubMed ID: 29789008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, characterization, and biological evaluation of novel diclofenac prodrugs.
    Bandgar BP; Sarangdhar RJ; Ahamed FA; Viswakarma S
    J Med Chem; 2011 Mar; 54(5):1202-10. PubMed ID: 21250699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminocarbonyloxymethyl ester prodrugs of flufenamic acid and diclofenac: suppressing the rearrangement pathway in aqueous media.
    Ribeiro L; Silva N; Iley J; Rautio J; Järvinen T; Mota-Filipe H; Moreira R; Mendes E
    Arch Pharm (Weinheim); 2007 Jan; 340(1):32-40. PubMed ID: 17206608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.